Atherosclerosis can be slowed, stabilized, and in some cases partially reversed through a combination of lifestyle changes and medical treatment. The process is slow, with measurable plaque regression taking roughly 20 months on average in clinical studies, but the arterial changes begin well before that. The key drivers are lowering LDL cholesterol aggressively, reducing inflammation, and addressing the lifestyle factors that accelerate plaque growth.
What Plaque Regression Actually Looks Like
Atherosclerotic plaques don’t simply dissolve. When conditions improve, the body removes lipids and dead cell debris from the artery wall, thickens the protective fibrous cap over the plaque, and shifts immune cells toward a cleanup mode that clears damaged tissue. The plaque may also calcify, which sounds alarming but actually makes it more stable and less likely to rupture. A ruptured plaque is what triggers heart attacks and strokes, so stabilizing existing plaque is just as important as shrinking it.
A key part of this process is reverse cholesterol transport, where cholesterol gets pulled out of the artery wall and shuttled to the liver for elimination. This only happens efficiently when LDL cholesterol levels drop low enough that the balance tips from cholesterol depositing into arteries to cholesterol leaving them.
How Low LDL Cholesterol Needs to Go
Current guidelines have progressively pushed LDL targets lower for people with established cardiovascular disease. The original U.S. recommendation was below 130 mg/dL, then below 100 mg/dL, then below 70 mg/dL. European and American cardiology groups now recommend getting below 55 mg/dL for higher-risk patients. Recent evidence suggests there is no lower bound where benefits stop, meaning the lower you can safely get your LDL, the better the outcomes.
For most people, achieving these levels requires medication. High-intensity statin therapy is the foundation, and it works through multiple pathways beyond just lowering cholesterol: statins also reduce inflammation and help stabilize plaques. A systematic review of 50 studies found that plaque regression with statin therapy occurred after an average of 19.7 months of treatment. That means you should expect roughly two years of consistent therapy before imaging would show measurable improvement.
For people who can’t reach their target on statins alone, a newer class of injectable medications (PCSK9 inhibitors) can drive LDL levels much lower. When added to statin therapy, these drugs reduced total plaque volume by an additional 7.1 cubic millimeters and percent plaque volume by 1.34% compared to statins alone. They also increased the thickness of the fibrous cap, making plaques more stable.
The Mediterranean Diet’s Effect on Arteries
Diet alone won’t reverse significant atherosclerosis, but the right dietary pattern measurably slows progression and can modestly reduce plaque size. The CORDIOPREV trial, published in the American Heart Association’s journal Stroke, tracked people with coronary heart disease for seven years. Those following a Mediterranean diet rich in extra virgin olive oil saw their carotid artery wall thickness decrease by 0.031 mm after seven years, while those on a standard low-fat diet saw no improvement. Carotid plaque height also dropped significantly in the Mediterranean diet group.
These are small numbers in absolute terms, but they represent the difference between arteries getting better and arteries staying the same. The Mediterranean pattern emphasizes olive oil, nuts, fish, vegetables, legumes, and whole grains while limiting red meat and processed foods.
A more extreme approach was tested in the Lifestyle Heart Trial led by Dean Ornish. Patients followed a 10% fat whole-foods vegetarian diet combined with aerobic exercise, stress management, and group support, all without cholesterol-lowering drugs. After five years, their coronary artery blockages improved by 7.9% relative to baseline. The control group, making only moderate changes, worsened by 27.7% over the same period, and experienced more than twice as many cardiac events.
Exercise That Improves Arterial Health
Physical activity reduces arterial stiffness, which is both a contributor to and consequence of atherosclerosis. The type and duration of exercise matter, but the threshold is achievable for most people.
For peripheral arteries (in your limbs), 30 minutes of moderate-intensity aerobic exercise, like cycling at about half your maximum effort, produces measurable improvements in arterial flexibility. High-intensity interval training, alternating 30-second bursts with 30-second rest periods for 30 minutes, works as well. Even light-intensity exercise helps: static squats performed in sets of one minute with one-minute rest periods reduced a key measure of systemic arterial stiffness.
Central arterial stiffness, which reflects the health of major vessels like the aorta, responds to longer or more sustained training programs. Studies show improvements with six weeks of interval training or with longer moderate-intensity sessions. The practical takeaway is that regular aerobic exercise of at least 30 minutes, most days, at moderate or higher intensity, is the minimum effective dose for arterial health.
Why Quitting Smoking Matters So Much
Smoking accelerates atherosclerosis through multiple pathways: it damages the artery lining, increases oxidized LDL (the form that drives plaque formation), and promotes inflammation. Quitting reverses these effects on a surprisingly fast timeline.
Blood pressure and heart rate stabilize within weeks. Oxidized LDL levels drop significantly within three months and continue improving through the first year. Within the first year after quitting, the risk of heart attack and stroke already declines markedly. After five years, coronary artery disease and stroke risk are considerably lower than in people who keep smoking. By 10 to 15 years, cardiovascular death risk becomes comparable to someone who never smoked.
No other single lifestyle change produces this magnitude of risk reduction this quickly.
Managing Inflammation
Atherosclerosis is fundamentally an inflammatory disease. Cholesterol deposits trigger an immune response in the artery wall, and that inflammation drives plaque growth and instability. High-sensitivity C-reactive protein (hs-CRP), a blood marker of inflammation, correlates directly with atherosclerosis severity. In studies of people with abnormal cholesterol levels, those with severe atherosclerosis had median hs-CRP levels more than double those without atherosclerosis.
You can lower systemic inflammation through the same lifestyle changes that reduce atherosclerosis directly: regular exercise, a plant-rich diet, maintaining a healthy weight, adequate sleep, and not smoking. Statins also have anti-inflammatory effects independent of their cholesterol-lowering action, which is one reason they’re effective even in people whose LDL isn’t dramatically elevated.
Purified Omega-3 Fatty Acids
Standard fish oil supplements have shown mixed results for heart disease, but a prescription-grade purified form of EPA (one specific omega-3 fatty acid) appears to offer real plaque benefits. In a study of 80 people with coronary artery disease, those taking 4 grams of purified EPA daily for 18 months had less unstable plaque and lower total plaque volume compared to a placebo group. This is a high dose, far more than a typical fish oil capsule provides, and the purified formulation matters. Over-the-counter fish oil is not a substitute.
Realistic Timelines and Expectations
The body can begin repairing arterial damage relatively quickly once conditions change, but visible plaque regression takes time. Endothelial function (how well your artery lining works) can improve within weeks to months of lifestyle changes or starting medication. Plaque stabilization, where existing plaques become less likely to rupture, begins in the first months of aggressive LDL lowering. Actual reduction in plaque volume takes closer to two years on average.
The Ornish trial showed more regression at five years than at one year, suggesting the process is cumulative and ongoing. The CORDIOPREV diet trial found improvements persisting and deepening from year five to year seven. This is not a quick fix. It is a sustained shift in how you eat, move, and manage risk factors, supported by medication when needed, that gradually reverses years of arterial damage.
What matters most is consistency. People in the Ornish trial who maintained their intensive lifestyle changes for five years saw continued improvement, while control patients who made only moderate changes saw steady worsening. The gap between the two groups widened every year. Starting earlier and staying consistent produces the best results, but the arteries retain the capacity to improve at any stage of disease.